These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

386 related articles for article (PubMed ID: 36186141)

  • 1. Discerning the Role of Blood Brain Barrier Dysfunction in Alzheimer's Disease.
    Tao QQ; Lin RR; Chen YH; Wu ZY
    Aging Dis; 2022 Oct; 13(5):1391-1404. PubMed ID: 36186141
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blood-brain barrier dysfunction and Alzheimer's disease: associations, pathogenic mechanisms, and therapeutic potential.
    Chen Y; He Y; Han J; Wei W; Chen F
    Front Aging Neurosci; 2023; 15():1258640. PubMed ID: 38020775
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of Blood-Brain Barrier in Alzheimer's Disease.
    Cai Z; Qiao PF; Wan CQ; Cai M; Zhou NK; Li Q
    J Alzheimers Dis; 2018; 63(4):1223-1234. PubMed ID: 29782323
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dysfunction of the blood-brain barrier in Alzheimer's disease: Evidence from human studies.
    Kurz C; Walker L; Rauchmann BS; Perneczky R
    Neuropathol Appl Neurobiol; 2022 Apr; 48(3):e12782. PubMed ID: 34823269
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reversing pathology in a preclinical model of Alzheimer's disease by hacking cerebrovascular neoangiogenesis with advanced cancer therapeutics.
    Singh CSB; Choi KB; Munro L; Wang HY; Pfeifer CG; Jefferies WA
    EBioMedicine; 2021 Sep; 71():103503. PubMed ID: 34534764
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mast Cells in Stress, Pain, Blood-Brain Barrier, Neuroinflammation and Alzheimer's Disease.
    Kempuraj D; Mentor S; Thangavel R; Ahmed ME; Selvakumar GP; Raikwar SP; Dubova I; Zaheer S; Iyer SS; Zaheer A
    Front Cell Neurosci; 2019; 13():54. PubMed ID: 30837843
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HMGB1 and thrombin mediate the blood-brain barrier dysfunction acting as biomarkers of neuroinflammation and progression to neurodegeneration in Alzheimer's disease.
    Festoff BW; Sajja RK; van Dreden P; Cucullo L
    J Neuroinflammation; 2016 Aug; 13(1):194. PubMed ID: 27553758
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blood-brain barrier breakdown is an early biomarker of human cognitive dysfunction.
    Nation DA; Sweeney MD; Montagne A; Sagare AP; D'Orazio LM; Pachicano M; Sepehrband F; Nelson AR; Buennagel DP; Harrington MG; Benzinger TLS; Fagan AM; Ringman JM; Schneider LS; Morris JC; Chui HC; Law M; Toga AW; Zlokovic BV
    Nat Med; 2019 Feb; 25(2):270-276. PubMed ID: 30643288
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Necroptosis and Alzheimer's Disease: Pathogenic Mechanisms and Therapeutic Opportunities.
    Zhang R; Song Y; Su X
    J Alzheimers Dis; 2023; 94(s1):S367-S386. PubMed ID: 36463451
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of Tau on Neurovascular Pathology in Alzheimer's Disease.
    Canepa E; Fossati S
    Front Neurol; 2020; 11():573324. PubMed ID: 33488493
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interactions between Amyloid-Β Proteins and Human Brain Pericytes: Implications for the Pathobiology of Alzheimer's Disease.
    Alcendor DJ
    J Clin Med; 2020 May; 9(5):. PubMed ID: 32429102
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unveiling the impact of aging on BBB and Alzheimer's disease: Factors and therapeutic implications.
    Kumar Nelson V; Jha NK; Nuli MV; Gupta S; Kanna S; Gahtani RM; Hani U; Singh AK; Abomughaid MM; Abomughayedh AM; Almutary AG; Iqbal D; Al Othaim A; Begum SS; Ahmad F; Mishra PC; Jha SK; Ojha S
    Ageing Res Rev; 2024 Jul; 98():102224. PubMed ID: 38346505
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alzheimer's disease: A matter of blood-brain barrier dysfunction?
    Montagne A; Zhao Z; Zlokovic BV
    J Exp Med; 2017 Nov; 214(11):3151-3169. PubMed ID: 29061693
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Review of evidence implicating the plasminogen activator system in blood-brain barrier dysfunction associated with Alzheimer's disease.
    Tang MY; Gorin FA; Lein PJ
    Ageing Neurodegener Dis; 2022; 2():. PubMed ID: 35156107
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Brain capillaries in Alzheimer's disease.
    Baloyannis SJ
    Hell J Nucl Med; 2015; 18 Suppl 1():152. PubMed ID: 26665235
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impaired Amyloid Beta Clearance and Brain Microvascular Dysfunction are Present in the Tg-SwDI Mouse Model of Alzheimer's Disease.
    Rosas-Hernandez H; Cuevas E; Raymick JB; Robinson BL; Sarkar S
    Neuroscience; 2020 Aug; 440():48-55. PubMed ID: 32450297
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic potentials of plant iridoids in Alzheimer's and Parkinson's diseases: A review.
    Dinda B; Dinda M; Kulsi G; Chakraborty A; Dinda S
    Eur J Med Chem; 2019 May; 169():185-199. PubMed ID: 30877973
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ultrasound with microbubbles improves memory, ameliorates pathology and modulates hippocampal proteomic changes in a triple transgenic mouse model of Alzheimer's disease.
    Shen Y; Hua L; Yeh CK; Shen L; Ying M; Zhang Z; Liu G; Li S; Chen S; Chen X; Yang X
    Theranostics; 2020; 10(25):11794-11819. PubMed ID: 33052247
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blood-brain barrier dysfunction as a cause and consequence of Alzheimer's disease.
    Erickson MA; Banks WA
    J Cereb Blood Flow Metab; 2013 Oct; 33(10):1500-13. PubMed ID: 23921899
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alzheimer's disease.
    De-Paula VJ; Radanovic M; Diniz BS; Forlenza OV
    Subcell Biochem; 2012; 65():329-52. PubMed ID: 23225010
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.